Multi-locus approach in pharmacogenetics. Application in the cholesterol lowering and anti-inflammatory pathways of statins

Multi-locus approach in pharmacogenetics. Application in the cholesterol lowering and anti-inflammatory pathways of statins - Multi-locus approach in pharmacogenetics of statins

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON29788

Enrollment

2400

Registered

2006-08-29

Start date

2007-01-27

Completion date

Unknown

Last updated

2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial infarction

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: age > 18 years Hypercholesterolemia: defined as total cholesterol levels >5 mmol/l or use of cholesterol lowering medication

Exclusion criteria

Exclusion criteria: controls: Myocardial infarction in medical history

Design outcomes

Primary

Measure	Time frame
We will use different statistical methods to study the interaction between statin use, SNPs, and MI.	—

Countries

Netherlands

Outcome results